On the other hand, a novel drug targeting the splicing factor SRSF1, ABX300, has been shown to impair SRSF1 splicing activity to treat diet-induced obesity in mice without any observed toxicity47. The gene discussed is SRSF1; the disease is obesity due to melanocortin 4 receptor deficiency.